SCHEMBL7263294

SCHEMBL7263294

C[C@H](O)[C@H](CCOc1ccc2ncccc2c1)c1nc(C(N)=O)c[nH]1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADA P00813 1/20 0.47
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
ALOX5 P09917 1/20 0.42
ALDH1A1 P00352 4/20 0.41
MCL1 Q07820 1/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
NR2F2 P24468 1/20 0.38
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 3/20 0.36
RECQL P46063 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263602 0.86 PPARG (0.41) ADAPPARGPPARAALOX5ALDH1A1
SCHEMBL7259601 0.83 ADA (0.44) ADAPPARGPPARAALDH1A1RAB9A
SCHEMBL7258942 0.82 ADA (0.43) ADAALDH1A1SMN1; SMN2KDM4ELMNA
SCHEMBL7263915 0.82 ADA (0.48) ADAPPARGPPARA
SCHEMBL7263299 0.82 ADA (0.48) ADAPPARGPPARASMN1; SMN2MAPK1
SCHEMBL7263103 0.79 ADA (0.46) ADAPPARGPPARAALDH1A1KDM4E
SCHEMBL7263874 0.79 ADA (0.43) ADAALDH1A1KDM4EMAPTCYP3A4
SCHEMBL7263886 0.77 ADA (0.41) ADAALDH1A1RAB9ASMN1; SMN2KDM4E
SCHEMBL5670994 0.76 ADA (0.80) ADAPPARGPPARAALOX5ALDH1A1
SCHEMBL7448841 0.76 ALDH1A1 (0.42) ADAALDH1A1MCL1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003006437-A1 IMIDAZOLE DERIVATIVES AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-01-23 WO claimed